Viewing Study NCT04649359

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:35 PM

Ignite Modification Date: 2026-01-06 @ 11:11 PM

Study NCT ID: NCT04649359

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-12-02

First Post: 2020-11-06

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

Sponsor: Pfizer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module